{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:40:42Z","timestamp":1759452042166,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vaccine.2023.10.004","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T01:11:01Z","timestamp":1696554661000},"page":"6727-6733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A multicenter study on the epidemiology of complicated parapneumonic effusion in the era of currently available pneumococcal conjugate vaccines"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0619-8316","authenticated-orcid":false,"given":"Smaragda","family":"Papachristidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Lapea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Charisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Kourkouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Kousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasia","family":"Xirogianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Dedousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Papaconstadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Krepis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Pasparaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3553-8893","authenticated-orcid":false,"given":"Georgios","family":"Pantalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-5896","authenticated-orcid":false,"given":"Anastasios","family":"Doudoulakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisavet","family":"Bozavoutoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Daskalaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavroula","family":"Kostaridou \u2013 Nikolopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Tzanakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vana","family":"Spoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-4409","authenticated-orcid":false,"given":"Maria","family":"Tsolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2023.10.004_b0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1542\/pir.23.12.417","article-title":"Pleural Effusions in the Pediatric Population","volume":"23","author":"Efrati","year":"2002","journal-title":"Pediatr Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2023.10.004_b0010","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00431-009-0929-9","article-title":"Clinical practice: treatment of childhood empyema","volume":"168","author":"Proesmans","year":"2009","journal-title":"Eur J Pediatr"},{"issue":"11","key":"10.1016\/j.vaccine.2023.10.004_b0015","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jpedsurg.2012.07.047","article-title":"The diagnosis and management of empyema in children: a comprehensive review from the APSA Outcomes and Clinical Trials Committee","volume":"47","author":"Islam","year":"2012","journal-title":"J Pediatr Surg"},{"issue":"2","key":"10.1016\/j.vaccine.2023.10.004_b0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-3468(00)90022-8","article-title":"Management of parapneumonic collections in infants and children","volume":"35","author":"Doski","year":"2000","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.vaccine.2023.10.004_b0025","doi-asserted-by":"crossref","unstructured":"Redden M, Chin T, van Driel. Surgical versus non-surgical management for pleural empyema.Cochrane Database of Systematic Reviews. 2017;3:CD010651.","DOI":"10.1002\/14651858.CD010651.pub2"},{"issue":"5","key":"10.1016\/j.vaccine.2023.10.004_b0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1590\/s1806-37562016000000261","article-title":"Parapneumonic pleural effusion: early versus late thoracoscopy","volume":"43","author":"Pereira","year":"2017","journal-title":"J Bras Pneumol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.10.004_b0035","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jpedsurg.2017.07.017","article-title":"Evolution of practice in the management of parapneumonic effusion and empyema in children","volume":"53","author":"Griffith","year":"2018","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.004_b0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0009922815589917","article-title":"Parapneumonic effusion in children","volume":"55","author":"Hendaus","year":"2016","journal-title":"Clin Pediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2023.10.004_b0045","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jiac.2013.12.006","article-title":"Thoracic empyema in children: clinical presentation, microbiology analysis and therapeutic options","volume":"20","author":"Sakran","year":"2014","journal-title":"J Infect Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.004_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-12-207","article-title":"Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective","volume":"12","author":"Weil-Olivier","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.10.004_b0055","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-014-2062-6","article-title":"Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology","volume":"33","author":"Fletcher","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.004_b0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1542\/peds.2009-0184","article-title":"Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine","volume":"125","author":"Li","year":"2010","journal-title":"Pediatrics"},{"issue":"50","key":"10.1016\/j.vaccine.2023.10.004_b0065","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.vaccine.2016.10.062","article-title":"Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era","volume":"34","author":"Wiese","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2023.10.004_b0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.inf.0000202137.37642.ab","article-title":"Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema","volume":"25","author":"Byington","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2023.10.004_b0075","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/650573","article-title":"Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States","volume":"50","author":"Grijalva","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2023.10.004_b0080","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/INF.0b013e31817e5188","article-title":"Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine","volume":"27","author":"Hendrickson","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2023.10.004_b0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jinf.2015.06.011","article-title":"Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England","volume":"71","author":"Saxena","year":"2015","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2023.10.004_b0090","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.vaccine.2015.12.066","article-title":"Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2\u20136 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands","volume":"34","author":"Wagenvoort","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.10.004_b0095","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jiac.2016.01.016","article-title":"Clinical characteristics of 323 children with parapneumonic pleural effusion and pleural empyema due to community acquired pneumonia","volume":"22","author":"Krenke","year":"2016","journal-title":"J Infect Chemother"},{"issue":"14","key":"10.1016\/j.vaccine.2023.10.004_b0100","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.10.004_b0105","doi-asserted-by":"crossref","unstructured":"CDC.Direct and Indirect Effects of Routine Vaccination of Children With 7-Valent Pneumococcal Conjugate Vaccine on Incidence of Invasive Pneumococcal Disease--United States, 1998-2003. JAMA: The Journal of the American Medical Association, 2015;294(16):2022-2026.","DOI":"10.1001\/jama.294.16.2022"},{"issue":"2","key":"10.1016\/j.vaccine.2023.10.004_b0110","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JCM.01200-09","article-title":"Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah","volume":"48","author":"Byington","year":"2009","journal-title":"J Clin Micobiol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.10.004_b0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/INF.0b013e31820a418a","article-title":"Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in madrid","volume":"30","author":"Picazo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2023.10.004_b0120","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1016\/j.vaccine.2011.06.096","article-title":"Pneumococcal disease manifestation in children before and after vaccination: what's new?","volume":"29","author":"Andrade","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2023.10.004_b0125","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/656579","article-title":"Community-acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real-time polymerase chain reaction using blood samples","volume":"51","author":"Resti","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2023.10.004_b0130","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pediatric pneumococcal serotypes in 4 European Countries","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2023.10.004_b0135","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the united states during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.10.004_b0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/children5030036","article-title":"Trends in pediatric complicated pneumonia in an ontario local health integration network","volume":"5","author":"Haji","year":"2018","journal-title":"Children"},{"key":"10.1016\/j.vaccine.2023.10.004_b0145","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010\u20132017: a nationwide surveillance study","author":"Liese","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2023.10.004_b0150","doi-asserted-by":"crossref","first-page":"e0206912","DOI":"10.1371\/journal.pone.0206912","article-title":"Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012\u20132015)","volume":"13","author":"Hor\u00e1cio","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.004_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36799-x","article-title":"Dominance of vaccine serotypes in pediatric invasive pneumococcal infections in Portugal (2012\u20132015)","volume":"9","author":"Silva-Costa","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.004_b0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1147-x","article-title":"Pneumococcal serotype evolution in Western Europe","volume":"15","author":"Tin Tin Htar","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2023.10.004_b0165","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/jpc.13172","article-title":"Incidence, aetiology and outcome of pleural empyema and parapneumonic effusion from 1998 to 2012 in a population of New Zealand children","volume":"52","author":"Mahon","year":"2016","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2023.10.004_b0170","unstructured":"National Immunnization Committee \u2013 National Immunization Programme 2017, https:\/\/www.moh.gov.gr\/articles\/health\/dieythynsh-dhmosias-ygieinhs\/metadotika-kai-mh-metadotika-noshmata\/ethnika-programmata-emboliasmwn\/5775-ethniko-programma-emboliasmwn-paidiwn-kai-efhbwn-2017."},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.004_b0175","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-13-908","article-title":"Immunization coverage and predictive factors for complete and age-appropriate vaccination among preschoolers in Athens, Greece: a cross- sectional study","volume":"13","author":"Pavlopoulou","year":"2013","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2023.10.004_b0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/INF.0000000000000041","article-title":"Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine","volume":"33","author":"Antachopoulos","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2023.10.004_b0185","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/23744235.2016.1192720","article-title":"Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine","volume":"48","author":"Syrogiannopoulos","year":"2016","journal-title":"Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2023.10.004_b0190","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1469-0691.2005.01109.x","article-title":"Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae","volume":"11","author":"Tzanakaki","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2023.10.004_b0195","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/diagnostics3020222","article-title":"Diagnosis of upper and lower respiratory tract bacterial infections with the use of multiplex PCR assays","volume":"3","author":"Xirogianni","year":"2013","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.vaccine.2023.10.004_b0200","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3390\/diagnostics11122353","article-title":"Pneumococcal serotype identification by capsular sequence typing (CST): a modified novel approach for serotyping directly in clinical samples","volume":"11","author":"Marmaras","year":"2021","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.vaccine.2023.10.004_b0220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.vaccine.2017.11.054","article-title":"Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec","volume":"36","author":"De Wals","year":"2018","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2023.10.004_b0225","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/cid\/cix418","article-title":"Characteristics and serotype distribution of childhood cases of invasive pneumococcal disease following pneumococcal conjugate vaccination in England and Wales, 2006\u20132014","volume":"65","author":"Oligbu","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2023.10.004_b0230","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2213-2600(16)00052-7","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study","volume":"4","author":"Moore","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.vaccine.2023.10.004_b0235","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2023.10.004_b0240","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/cid\/cix310","article-title":"Childhood deaths attributable to invasive pneumococcal disease in England and Wales, 2006\u20132014","volume":"65","author":"Oligbu","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2023.10.004_b0245","first-page":"109","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: Updated recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022. MMWR Morbidity and Mortality Weekly","volume":"71","author":"Kobayashi","year":"2022","journal-title":"Report"},{"key":"10.1016\/j.vaccine.2023.10.004_b0250","unstructured":"ACIP vaccine recommendations and Schedules [Internet]. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention; 2021 [cited 2022Jul29]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip \/recommendations.html."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23011647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23011647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:30:20Z","timestamp":1759404620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23011647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":47,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0264410X23011647"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter study on the epidemiology of complicated parapneumonic effusion in the era of currently available pneumococcal conjugate vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}